Analyst Consensus ?
ConsensusBuy27 ratings
Bullish2592.6%
Neutral27.4%
Bearish00.0%
Cheniere Energy, Inc. · LNG · FY2026 Q2 · Calendar Q3 2026
Cheniere raises 2026 outlook as LNG capacity and margins strengthen
Cheniere's Q2 analysis supports a constructive operating outlook: new capacity, higher marketing margins, long-term contracts and reliability improvements are strengthening cash-flow visibility. The main counterweights are market exposure, geopolitical uncertainty, permitting and upcoming maintenance.
Reported Before market openNYSEEnergy
$68.22B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$14.65
Consensus $3.11
EPS surprise
+371.1%
Reported versus consensus
Reported revenue
$5.73B
Consensus $4.92B
Revenue surprise
+16.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+4.3%
Event window
SPY move
-0.2%
Same window
Abnormal move
+4.5%
Stock minus SPY
Volume
1.2×
Versus trailing sessions
Subsequent drift
+9.4%
Up to 20 sessions
LNGSPY benchmark
Ask FN2 about LNG FY2026 Q2
Transcript, numbers and history already loaded
Why did LNG rise 4.3% after beating EPS estimates in FY2026 Q2?What changed in LNG's guidance and outlook in FY2026 Q2?Give me the bull and bear case for LNG after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management raised full-year 2026 adjusted EBITDA guidance to $7.9-$8.4 billion and distributable cash flow guidance to $5.3-$5.8 billion. The analysis also highlights a 20% year-over-year increase in exported cargoes, progress on Train 7 and a $4.7 billion EPC contract for the Phase 1 Sabine Pass expansion.
Guidance delta
Raised: full-year 2026 adjusted EBITDA guidance increased to $7.9-$8.4 billion and distributable cash flow guidance to $5.3-$5.8 billion.
Key takeaways
- New capacity and early Train 7 progress are supporting higher production and exports.
- Operational reliability, debottlenecking and marketing optimization contributed to stronger margins.
- Long-term contracts and the IPM accounting change are intended to improve cash-flow visibility and reduce earnings volatility.
- Growth investment continues through the Phase 1 Sabine Pass expansion and Trains 8-9.
Management priorities
- Complete and ramp Train 7 and continue progress on Trains 8-9.
- Execute the Phase 1 Sabine Pass expansion, including the boil-off gas reliquefaction unit.
- Optimize open volumes and secure cargoes for 2026-2027.
- Continue dividend growth and share repurchases.
Follow LNG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$330.32Current
$115Low
$245.97Average
$340High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 30, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 23, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 24, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 11, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 2, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 24, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 23, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 20, 2026 |
| UBS | Buy | Buy | Maintain | Mar 3, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jan 14, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Aug 29, 2025 |
| Stifel | Buy | Buy | Maintain | Apr 22, 2025 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 20, 2023 |
| CFRA | Hold | Hold | Maintain | May 1, 2020 |
| Bank of America | Buy | Buy | Maintain | May 8, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 7, 2018 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Jun 14, 2016 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 3, 2014 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 2, 2014 |
| BTIG Research | Buy | Buy | Maintain | Nov 18, 2013 |
| BTIG | Buy | Buy | Maintain | Nov 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $330.32. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $340 | $287.84 | +2.9% | Oct 19, 2026 |
| Scotiabank | Analyst unavailable | $311 | $278.59 | -5.8% | Oct 15, 2026 |
| Jefferies | Emma Schwartz | $336 | $278.18 | +1.7% | Oct 10, 2026 |
| Barclays | Analyst unavailable | $287 | $275.26 | -13.1% | Oct 7, 2026 |
| Scotiabank | Analyst unavailable | $312 | $279.48 | -5.5% | Sep 10, 2026 |
| RBC Capital | Elvira Scotto | $319 | $277.45 | -3.4% | Aug 24, 2026 |
| Argus Research | Analyst unavailable | $330 | $274.24 | -0.1% | Aug 18, 2026 |
| Morgan Stanley | Devin McDermott | $310 | $263.17 | -6.2% | Aug 7, 2026 |
| Barclays | Analyst unavailable | $279 | $265.77 | -15.5% | Aug 7, 2026 |
| Barclays | Theresa Chen | $274 | $265.03 | -17.1% | Jul 15, 2026 |
| Bernstein | Analyst unavailable | $283 | $230.86 | -14.3% | Jun 16, 2026 |
| Wolfe Research | Keith Stanley | $300 | $227.88 | -9.2% | Jun 2, 2026 |
| UBS | Analyst unavailable | $290 | $241.98 | -12.2% | May 13, 2026 |
| Scotiabank | Analyst unavailable | $288 | $263.26 | -12.8% | Apr 16, 2026 |
| UBS | Manav Gupta | $340 | $291.4 | +2.9% | Mar 26, 2026 |
| UBS | Manav Gupta | $301 | $252.64 | -8.9% | Mar 3, 2026 |
| Morgan Stanley | Devin McDermott | $236 | $223.35 | -28.6% | Feb 24, 2026 |
| Jefferies | Analyst unavailable | $251 | $207.35 | -24.0% | Jan 25, 2026 |
| Scotiabank | Brandon Bingham | $266 | $206.72 | -19.5% | Jan 16, 2026 |
| Barclays | Theresa Chen | $259 | $199.72 | -21.6% | Jan 15, 2026 |
| Wolfe Research | Analyst unavailable | $220 | $193.69 | -33.4% | Jan 14, 2026 |
| BMO Capital | Ameet Thakkar | $254 | $189.28 | -23.1% | Dec 17, 2025 |
| Goldman Sachs | John Mackay | $275 | $212 | -16.7% | Nov 3, 2025 |
| Jefferies | Analyst unavailable | $290 | $211.52 | -12.2% | Oct 30, 2025 |
| Raymond James | Analyst unavailable | $278 | $222.24 | -15.8% | Oct 24, 2025 |
| Mizuho Securities | Analyst unavailable | $273 | $242.14 | -17.4% | Aug 29, 2025 |
| Scotiabank | Brandon Bingham | $261 | $236.96 | -21.0% | Jul 15, 2025 |
| Jefferies | Sam Burwell | $288 | $236.32 | -12.8% | Jun 26, 2025 |
| Wells Fargo | Michael Blum | $267 | $236.32 | -19.2% | Jun 25, 2025 |
| UBS | Manav Gupta | $277 | $223.39 | -16.1% | Mar 18, 2025 |
| Argus Research | Analyst unavailable | $255 | $224.03 | -22.8% | Mar 18, 2025 |
| Morgan Stanley | Devin McDermott | $255 | $223.65 | -22.8% | Jan 31, 2025 |
| Mizuho Securities | Robert Mosca | $214 | $183.58 | -35.2% | Oct 29, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $215 | $182.58 | -34.9% | Oct 17, 2024 |
| Barclays | Theresa Chen | $202 | $188.77 | -38.8% | Oct 15, 2024 |
| Bernstein | Bob Brackett | $217 | $167.62 | -34.3% | Jun 24, 2024 |
| Stifel Nicolaus | Benjamin Nolan | $208 | $157.54 | -37.0% | May 6, 2024 |
| Redburn Partners | Peter Low | $162 | $154.43 | -51.0% | Apr 16, 2024 |
| Mizuho Securities | Robert Mosca | $187 | $149.16 | -43.4% | Jun 22, 2023 |
| Barclays | Analyst unavailable | $192 | $153.47 | -41.9% | Jan 13, 2023 |
| Citigroup | Analyst unavailable | $190 | $143.49 | -42.5% | Jan 9, 2023 |
| Citigroup | Analyst unavailable | $205 | $163.1 | -37.9% | Dec 9, 2022 |
| Wells Fargo | Analyst unavailable | $162 | $138.4 | -51.0% | Apr 28, 2022 |
| Raymond James | Analyst unavailable | $165 | $139.26 | -50.0% | Apr 20, 2022 |
| Wolfe Research | Steve Fleishman | $151 | $129.25 | -54.3% | Feb 25, 2022 |
| Mizuho Securities | Robert Mosca | $145 | $129.25 | -56.1% | Feb 25, 2022 |
| Cowen & Co. | Jason Gabelman | $145 | $129.25 | -56.1% | Feb 25, 2022 |
| UBS | Shneur Gershuni | $145 | $104.83 | -56.1% | Jan 24, 2022 |
| Wells Fargo | Michael Blum | $123 | $100.57 | -62.8% | Dec 16, 2021 |
| J.P. Morgan | Jeremy Tonet | $133 | $104.64 | -59.7% | Oct 22, 2021 |
| Citigroup | Timm Schneider | $115 | $89.44 | -65.2% | Sep 8, 2021 |
Track every rating change on LNG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCheniere Energy, Inc. is an energy infrastructure firm predominantly focused on liquefied natural gas (LNG) related activities within the United States. The company owns and operates two significant LNG terminals: one in Sabine Pass, located in Cameron Parish, Louisiana, and another near Corpus Christi, Texas. Beyond its terminals, Cheniere also owns the 94-mile Creole Trail pipeline, which serves to connect the Sabine Pass LNG Terminal with various interstate and intrastate pipelines. It further manages the 21.5-mile Corpus Christi pipeline, ensuring the Corpus Christi LNG terminal is linked to a diverse network of natural gas pipelines, both within and across state lines. The company also participates in the marketing of LNG and natural gas. Cheniere Energy, Inc. was established in 1983 and has its corporate headquarters in Houston, Texas.
Historical context
All LNG earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| BP BP p.l.c. | FY2026 Q3 · Calendar Q4 2026 | +22.6% | +0.1% | BP Q3: Strong profit, lower debt, safety risks persist |
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +1.8% | Chevron highlights record production, AI value and expansion plans |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +1.6% | ExxonMobil emphasizes project execution and shareholder returns |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | — | +4.1% | Imperial Oil leans on downstream strength and low-carbon growth |
| CCJ Cameco Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -9.8% | Cameco keeps nuclear-demand outlook intact as costs and execution stay in focus |
| FSLR First Solar, Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.5% | -1.4% | First Solar: Margin gains offset lower volume outlook |
Latest beats and misses
Who reports nextBeat on EPS
- BTSGUFY2026 Q3 · October 30, 2026+14.2% EPS+10.0% move
- NVTFY2026 Q3 · October 30, 2026+8.6% EPS-8.8% move
- BPFY2026 Q3 · October 30, 2026+22.6% EPS+0.1% move
- NWGFY2026 Q3 · October 30, 2026+2.0% EPS-9.0% move
- REGNFY2026 Q3 · October 30, 2026+21.6% EPS+13.3% move
- WYFY2026 Q3 · October 29, 2026+128.3% EPS+3.0% move
Get the LNG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-06T21:18:09.018934+00:00
- FN2 earnings calendar · 2026-09-11T01:23:15.000588+00:00
- Polygon adjusted daily market bars · 2026-10-31T03:40:42.575990+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T03:40:42.572640+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.